• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种、感染与混合免疫:中国衢州新冠病毒 IgG 抗体水平及保护作用的决定因素

Vaccination, infection, and hybrid immunity: determinants of SARS-CoV-2 IgG antibody levels and protection in Quzhou, China.

作者信息

Yin Zhiying, Yin Mengcheng, Zhao Fei, Fu Canya, Xu Wenjie, Fang Quanjun, Gong Xiaoying, Cao Guoping, Zheng Canjie

机构信息

Department of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.

Second Clinical Medical College, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

出版信息

Front Immunol. 2025 Jul 28;16:1576016. doi: 10.3389/fimmu.2025.1576016. eCollection 2025.

DOI:10.3389/fimmu.2025.1576016
PMID:40791592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12336225/
Abstract

OBJECTIVES

To investigate the factors influencing SARS-CoV-2 IgG antibody levels and protection in a population that has experienced both vaccination and COVID-19 infections, predominantly caused by the Omicron BA.5.2 and BF.7 variants.

METHODS

Anti-SARS-CoV-2 IgG antibody levels were measured using chemiluminescent microparticle immunoassay (CMIA). Multivariate regression analyses assessed factors influencing antibody levels, and decision tree models predicted variable priorities.

RESULTS

Among the 3494 participants, the median (IQR) anti-SARS-CoV-2 IgG level was 396.53 (280.51-471.03) AU/mL, with a seropositive rate of 97.28%. Multivariate analysis revealed that vaccination status, infection status, residence county, occupation, and vaccination interval were significantly associated with antibody concentration. The decision tree model indicated that vaccination had a greater effect on antibody concentration than infection, while infection had a stronger impact on seropositivity. The Breakthrough Infection group had the highest antibody concentration compared with other groups.

CONCLUSIONS

Vaccination and infection were identified as the primary determinants of SARS-CoV-2 IgG antibody levels, with hybrid immunity significantly enhancing antibody responses. New evaluation methods or revised detection thresholds were needed to better assess population immunity.

摘要

目的

在一个既接种过疫苗又感染过新冠病毒(主要由奥密克戎BA.5.2和BF.7变异株引起)的人群中,调查影响新冠病毒SARS-CoV-2 IgG抗体水平及保护作用的因素。

方法

采用化学发光微粒子免疫分析(CMIA)测定抗SARS-CoV-2 IgG抗体水平。多因素回归分析评估影响抗体水平的因素,决策树模型预测变量优先级。

结果

在3494名参与者中,抗SARS-CoV-2 IgG水平的中位数(四分位间距)为396.53(280.51 - 471.03)AU/mL,血清阳性率为97.28%。多因素分析显示,疫苗接种状况、感染状况、居住县、职业和疫苗接种间隔与抗体浓度显著相关。决策树模型表明,疫苗接种对抗体浓度的影响大于感染,而感染对血清阳性率的影响更强。与其他组相比,突破性感染组的抗体浓度最高。

结论

疫苗接种和感染被确定为SARS-CoV-2 IgG抗体水平的主要决定因素,混合免疫显著增强抗体反应。需要新的评估方法或修订检测阈值以更好地评估人群免疫力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c96/12336225/72fe02194405/fimmu-16-1576016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c96/12336225/972af60b692a/fimmu-16-1576016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c96/12336225/5659ed0b79bb/fimmu-16-1576016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c96/12336225/72fe02194405/fimmu-16-1576016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c96/12336225/972af60b692a/fimmu-16-1576016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c96/12336225/5659ed0b79bb/fimmu-16-1576016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c96/12336225/72fe02194405/fimmu-16-1576016-g003.jpg

相似文献

1
Vaccination, infection, and hybrid immunity: determinants of SARS-CoV-2 IgG antibody levels and protection in Quzhou, China.疫苗接种、感染与混合免疫:中国衢州新冠病毒 IgG 抗体水平及保护作用的决定因素
Front Immunol. 2025 Jul 28;16:1576016. doi: 10.3389/fimmu.2025.1576016. eCollection 2025.
2
Comparison of SARS-CoV-2 IgG responses in hemodialysis patients and healthcare workers after COVID-19 vaccination.新冠病毒疫苗接种后血液透析患者与医护人员中新冠病毒IgG反应的比较。
Front Immunol. 2025 Jul 15;16:1586468. doi: 10.3389/fimmu.2025.1586468. eCollection 2025.
3
Dynamic monitoring of antibody titers in people living with HIV during Omicron epidemic: comparison between unvaccinated and vaccinated individuals.奥密克戎疫情期间HIV感染者抗体滴度的动态监测:未接种疫苗者与接种疫苗者的比较
BMC Infect Dis. 2025 Jul 30;25(1):962. doi: 10.1186/s12879-025-11387-3.
4
The Second Round of a Population-Based Seroprevalence Study of Anti-SARS-CoV-2 Antibodies and COVID-19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那斯普斯卡共和国第二轮基于人群的抗SARS-CoV-2抗体血清流行率研究及新冠疫苗接种评估
Influenza Other Respir Viruses. 2025 Jan;19(1):e70053. doi: 10.1111/irv.70053.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
6
SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study.秘鲁接种疫苗人群中新冠病毒特异性体液免疫和细胞免疫评估:一项横断面研究
PeerJ. 2025 Jul 15;13:e19651. doi: 10.7717/peerj.19651. eCollection 2025.
7
COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection.多发性硬化症患者的新冠病毒疫苗加强针:改善严重急性呼吸综合征冠状病毒2交叉变异抗体反应及保护效果预测
Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200443. doi: 10.1212/NXI.0000000000200443. Epub 2025 Jul 22.
8
The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2.早期使用康复期血浆治疗新冠病毒病对严重急性呼吸综合征冠状病毒2抗体反应的影响。
Microbiol Spectr. 2025 Jul;13(7):e0300624. doi: 10.1128/spectrum.03006-24. Epub 2025 Jun 9.
9
Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021.埃塞俄比亚2019冠状病毒病抗体血清流行率:2021年全国人口调查结果
PLoS One. 2025 May 6;20(5):e0313791. doi: 10.1371/journal.pone.0313791. eCollection 2025.
10
Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.在整个 COVID-19 大流行期间健康献血者的抗 SARS-CoV-2 总免疫球蛋白和中和抗体反应:一项纵向观察研究。
Swiss Med Wkly. 2024 Jul 1;154:3408. doi: 10.57187/s.3408.

本文引用的文献

1
Predicting high sensitivity C-reactive protein levels and their associations in a large population using decision tree and linear regression.使用决策树和线性回归预测大样本人群中的高敏C反应蛋白水平及其关联。
Sci Rep. 2024 Dec 5;14(1):30298. doi: 10.1038/s41598-024-81714-2.
2
Why does COVID-19 vaccine protection quickly wane?为什么新冠疫苗的保护作用会迅速减弱?
Science. 2024 Oct 18;386(6719):255-256. doi: 10.1126/science.adt9019. Epub 2024 Oct 17.
3
Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis.
年龄和性别对 SpikoGen 重组刺突蛋白疫苗免疫原性和反应原性的影响:一项事后分析。
Sci Rep. 2024 Sep 30;14(1):22631. doi: 10.1038/s41598-024-67945-3.
4
The Anti-SARS-CoV-2 S-Protein IgG, Which Is Detected Using the Chemiluminescence Microparticle Immunoassay (CMIA) in Individuals Having Either a History of COVID-19 Vaccination and/or SARS-CoV-2 Infection, Showed a High-Titer Neutralizing Effect.用化学发光微粒子免疫分析(CMIA)检测到的针对 SARS-CoV-2 刺突蛋白 IgG 的抗体,在有 COVID-19 疫苗接种史和/或 SARS-CoV-2 感染史的个体中,显示出高滴度的中和作用。
Viruses. 2024 Sep 3;16(9):1409. doi: 10.3390/v16091409.
5
The Assessment of Anti-SARS-CoV-2 Antibodies in Different Vaccine Platforms: A Systematic Review and Meta-Analysis of COVID-19 Vaccine Clinical Trial Studies.不同疫苗平台中抗SARS-CoV-2抗体的评估:一项关于COVID-19疫苗临床试验研究的系统评价和荟萃分析
Rev Med Virol. 2024 Nov;34(6):e2579. doi: 10.1002/rmv.2579.
6
Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals.混合免疫增强免疫功能低下个体对 COVID-19 多种变异株的交叉保护作用。
J Infect. 2024 Oct;89(4):106238. doi: 10.1016/j.jinf.2024.106238. Epub 2024 Aug 8.
7
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination.混合免疫对 SARS-CoV-2 的产生源于 IgG 抗体的血清学回忆,这些抗体由感染或接种疫苗明显印记。
Cell Rep Med. 2024 Aug 20;5(8):101668. doi: 10.1016/j.xcrm.2024.101668. Epub 2024 Aug 1.
8
Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors.检测未接种疫苗和接种疫苗的献血者中与原发性 SARS-CoV-2 感染相关的核衣壳抗体。
Emerg Infect Dis. 2024 Aug;30(8):1621-1630. doi: 10.3201/eid3008.240659. Epub 2024 Jul 9.
9
Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball Association.与美国国家篮球协会(NBA)中高度接种疫苗人群中 SARS-CoV-2 感染率显著增加相关的低抗体水平。
J Med Virol. 2024 Mar;96(3):e29505. doi: 10.1002/jmv.29505.
10
Study on the logic and effectiveness of crisis learning in the promotion policy adjustment: an observation based on the adjustment of COVID-19 prevention policy in China.关于危机学习在促进政策调整中的逻辑和效果的研究:基于中国新冠肺炎疫情防控政策调整的观察。
Front Public Health. 2024 Jan 5;11:1324420. doi: 10.3389/fpubh.2023.1324420. eCollection 2023.